Paclitaxel enhances tumoricidal potential of TRAIL via inhibition of MAPK in resistant gastric cancer cells.

Abstract:

:Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) holds promise for cancer therapy due to its unique capacity to selectively trigger apoptosis in cancer cells. However, TRAIL therapy is greatly hampered by its resistance. A preclinical successful strategy is to identify combination treatments that sensitize resistant cancers to TRAIL. In the present study, we fully assessed TRAIL sensitivity in 9 gastric cancer cell lines. We found combined administration of paclitaxel (PTX) markedly enhanced TRAIL-induced apoptosis in resistant cancer cells both in vitro and in vivo. The sensitization to TRAIL was accompanied by activation of mitochondrial apoptotic pathway, upregulation of TRAIL receptors and downregulation of anti-apoptotic proteins including C-IAP1, C-IAP2, Livin and Mcl-1. Noticeably, we found PTX could suppress the activation of mitogen-activated protein kinases (MAPKs). Inhibition of MAPKs using specific inhibitors (ERK inhibitor U0126, JNK inhibitor SP600125 and P38 inhibitor SB202190) facilitated TRAIL-mediated apoptosis and cytotoxicity. Additionally, SP600125 upregulated TRAL receptors as well as downregulated C-IAP2 and Mcl-1 suggesting the anti-apoptotic role of JNK. Thus, PTX-induced suppression of MAPKs may contribute to restoring TRAIL senstitivity. Collectively, our comprehensive analyses gave new insight into the role of PTX on enhancing TRAIL sensitivity, and provided theoretical references on the development of combination treatment in TRAIL-resistant gastric cancer.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Li L,Wen XZ,Bu ZD,Cheng XJ,Xing XF,Wang XH,Zhang LH,Guo T,Du H,Hu Y,Fan B,Ji JF

doi

10.3892/or.2016.4666

subject

Has Abstract

pub_date

2016-05-01 00:00:00

pages

3009-17

issue

5

eissn

1021-335X

issn

1791-2431

journal_volume

35

pub_type

杂志文章
  • Rapamycin induces p53-independent apoptosis through the mitochondrial pathway in non-small cell lung cancer cells.

    abstract::The mammalian target of rapamycin (mTOR) is a key kinase acting downstream of growth factor receptor PI3K and AKT signaling, leading to processes resulting in increased cell size and proliferation through translation control. Rapamycin, a specific inhibitor of mTOR, results predomin...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1855

    authors: Miyake N,Chikumi H,Takata M,Nakamoto M,Igishi T,Shimizu E

    更新日期:2012-09-01 00:00:00

  • CD44 variant 6 expression predicts response to treatment in advanced colorectal cancer.

    abstract::CD44 has diverse functions in cell-cell and cell-matrix interactions and may be a determinant of metastatic and invasive behaviour in carcinomas. CD44 variant 6 (CD44v6) has been postulated to be involved in both carcinogenesis and tumor progression. Therefore, we have examined CD44v6 expression in tumors from 57 pati...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.11.1.41

    authors: Bendardaf R,Lamlum H,Ristamäki R,Pyrhönen S

    更新日期:2004-01-01 00:00:00

  • Type III TGF-β receptor inhibits cell proliferation and migration in salivary glands adenoid cystic carcinoma by suppressing NF-κB signaling.

    abstract::It is known that the TGF-β superfamily receptors act as master regulators of cancer progression. However, alteration and role of type III TGF-β receptor (TβRIII, or betaglycan) as the most abundant of the TGF-β receptor has not been explored in salivary gland adenoid cystic carcinoma (ACC). Here, we reported that tumo...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4390

    authors: Xu D,Li D,Lu Z,Dong X,Wang X

    更新日期:2016-01-01 00:00:00

  • Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system.

    abstract::Though patients with EGFR mutations are initially responsive to EGFR-tyrosine kinase inhibitors (TKIs), most tumors ultimately acquire resistance to EGFR-TKIs. The most frequently reported mechanism is EGFR T790M mutation. In this study, using a droplet digital PCR (ddPCR) system, we assessed optimal conditions for a ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5567

    authors: Suzawa K,Yamamoto H,Ohashi K,Hashida S,Tomida S,Kubo T,Maki Y,Soh J,Tsukuda K,Kiura K,Miyoshi S,Toyooka S

    更新日期:2017-05-01 00:00:00

  • Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.

    abstract::Clear cell renal cell carcinoma (ccRCC) is the main subtype of malignant kidney cancer. Long non‑coding RNA (lncRNA) serves a key role in predicting survival in patients with cancer. The present study aimed to develop an lncRNA‑related signature of prognostic values for patients with ccRCC. RNA sequencing data of 454 ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6540

    authors: Liu T,Sui J,Zhang Y,Zhang XM,Wu WJ,Yang S,Xu SY,Hong WW,Peng H,Yin LH,Pu YP,Liang GY

    更新日期:2018-09-01 00:00:00

  • Paris saponin II inhibits human ovarian cancer cell-induced angiogenesis by modulating NF-κB signaling.

    abstract::The clinical applications of Rhizoma paridis in traditional Chinese medicine are well known. However, the therapeutic potential of Rhizoma paridis and its active component such as Paris saponin I (polyphyllin D) and Paris saponin II (PSII) (formosanin C) in cancer treatments have not yet been fully explored. Recent st...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3836

    authors: Yang M,Zou J,Zhu H,Liu S,Wang H,Bai P,Xiao X

    更新日期:2015-05-01 00:00:00

  • WT1 regulates cyclin A1 expression in K562 cells.

    abstract::The restricted expression of Wilms tumor 1 (WT1) and cyclin A1 (CCNA1) in normal tissues, as opposed to their abnormal expression in leukemia demonstrates the applicability of WT1 and CCNA1 as cancer antigens for immunotherapy, and as markers for prognosis and relapse. In this study, the WT1 and CCNA1 mRNA levels were...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7287

    authors: Pandey S,Moazam M,Ghimirey N,Kuerbitz SJ,Fraizer GC

    更新日期:2019-11-01 00:00:00

  • Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer.

    abstract::To evaluate the efficacy of long-term postoperative adjuvant chemotherapy with low-dose cisplatin (CDDP) plus 5-fluorouracil (5-FU) (CDDP/5-FU), we retrospectively examined 167 patients with squamous cell carcinoma of the esophagus who received the treatment after curative surgery (R0 resection). We classified the pat...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Shiozaki A,Yamagishi H,Itoi H,Fujiwara H,Kikuchi S,Okamoto K,Ichikawa D,Fuji N,Ochiai T,Sonoyama T,Ueda Y

    更新日期:2005-04-01 00:00:00

  • Gene module analysis of juvenile myelomonocytic leukemia and screening of anticancer drugs.

    abstract::Juvenile myelomonocytic leukemia (JMML) is a rare but severe primary hemopoietic system tumor of childhood, most frequent in children 4 years and younger. There are currently no specific anticancer therapies targeting JMML, and the underlying gene expression changes have not been revealed. To define molecular targets ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6709

    authors: Zhao W,Wang L,Yu Y

    更新日期:2018-12-01 00:00:00

  • miR-194 is a negative regulator of GEF-H1 pathway in melanoma.

    abstract::The incidence and associated mortality of melanoma continues to increase worldwide. At present, there is no curative therapy for advanced stage of melanoma. It is necessary to find new indicators of prognosis and therapeutic targets. Increasing evidence shows that miRNA can provide potential candidate biomarkers for m...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5020

    authors: Guo B,Hui Q,Zhang Y,Chang P,Tao K

    更新日期:2016-10-01 00:00:00

  • Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.

    abstract::Mesenchymal stem cells (MSCs) are known to migrate to tumor tissues and to play an important role in cancer progression. However, the effects of MSCs on tumor progression remain controversial. The purpose of the present study was to detect the effects of human umbilical cord-derived MSCs (hUC‑MSCs) on the human breast...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4109

    authors: Li T,Zhang C,Ding Y,Zhai W,Liu K,Bu F,Tu T,Sun L,Zhu W,Zhou F,Qi W,Hu J,Chen H,Sun X

    更新日期:2015-09-01 00:00:00

  • Identification and characterization of sexual dimorphism‑linked gene expression profile in hepatocellular carcinoma.

    abstract::Hepatocellular carcinoma (HCC) is sexually disparate in humans, with a significantly increased prevalence in males. The molecular mechanisms by which the inhibition or development of liver cancer are facilitated require further investigation with regard to sex factors affecting disease progression. In the present stud...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7217

    authors: Wu Y,Yao N,Feng Y,Tian Z,Yang Y,Zhao Y

    更新日期:2019-09-01 00:00:00

  • Ribozyme mediated down-regulation of thrombospondin receptor CD36 inhibits the growth of the human osteosarcoma cell line.

    abstract::Thrombospondin-1 (TSP1) is known to possess tumor suppressor functions. In contradiction, TSP1 enhances the stromal vascularization and growth of certain cancers. A cell adhesion receptor, CD36, has been shown to interact with a ligand TSP1. We studied how CD36 affects the growth of the osteosarcoma cell line (HOS) ex...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Yamazaki H,Handa A,Nishi M,Tokunaga T,Tomisawa M,Hatanaka H,Abe Y,Kijima H,Ueyama Y,Nakamura M

    更新日期:2004-02-01 00:00:00

  • Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors.

    abstract::Post-transcriptional modification of p53 by phosphorylation has been proposed as an important mechanism of p53 stabilization and functional regulation. However, little is known about the phosphorylation state of mutant p53 protein overexpressed in human tumors. We evaluated immunohistochemically the p53 phosphorylatio...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Matsumoto M,Furihata M,Kurabayashi A,Ohtsuki Y

    更新日期:2004-11-01 00:00:00

  • Suppression by incadronate of invasion and growth of A-375 human melanoma in mandible in nude mice.

    abstract::Frequent invasion of oral cancers into the neighboring jaw bones is a major cause of increased mortality. Moreover, majority of patients with these oral cancers suffer from functional inconveniences and esthetic disadvantages during clinical course and after surgical treatments. Understanding of the mechanisms underly...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Kitagawa Y,Hiraga T,Yura Y,Yoneda T

    更新日期:2005-02-01 00:00:00

  • Silk protein, sericin, suppresses DMBA-TPA-induced mouse skin tumorigenesis by reducing oxidative stress, inflammatory responses and endogenous tumor promoter TNF-alpha.

    abstract::This study was conducted to assess protective effect of an antioxidant protein, sericin, on tumor promotion in the 7,12-dimethylbenz (alpha) anthracene (DMBA)-initiated and 12-O-tetradecanoylphorbol 13-acetate (TPA)-promoted mouse skin tumorigenesis model. In experiment 1, sericin was applied topically to DMBA-initiat...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Zhaorigetu S,Yanaka N,Sasaki M,Watanabe H,Kato N

    更新日期:2003-05-01 00:00:00

  • Interference of STAT 5b expression enhances the chemo-sensitivity of gastric cancer cells to gefitinib by promoting mitochondrial pathway-mediated cell apoptosis.

    abstract::Signal transducer and activator of transcription (STAT) 5, including STAT 5a and STAT 5b, was reported to play important roles in the malignant biological behaviors of tumors. However, their roles in gastric cancer, especially for STAT 5b remain unknown. This study aimed to detect the expression of STAT 5b in gastric ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3994

    authors: Sun T,Jia Y,Xiao D

    更新日期:2015-07-01 00:00:00

  • N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma.

    abstract::N-myc downstream regulated gene 1 (NDRG1)/Cap43 is a 43 kDa protein that is widely distributed in the body. Its expression is regulated by nickel, cobalt, hypoxic condition and others; it is reported to be weaker in tumors than normal tissues; and NDRG1/Cap43 is considered to act suppressively to tumor metastasis. Thi...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Akiba J,Ogasawara S,Kawahara A,Nishida N,Sanada S,Moriya F,Kuwano M,Nakashima O,Yano H

    更新日期:2008-12-01 00:00:00

  • Clinical implication of the preoperative GSA index in ⁹⁹mTc-GSA scintigraphy in hepatitis C virus-related hepatocellular carcinoma.

    abstract::We aimed to examine the relationship between the preoperative GSA index [uptake ratio of the liver to the liver plus heart at 15 min (LHL15) to uptake ratio of the heart at 15 min to that at 3 min (HH15) ratio] calculated from 99mTc‑labeled diethylene triamine pentaacetate-galactosyl human serum albumin (99mTc-GSA) sc...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3691

    authors: Nishikawa H,Osaki Y,Komekado H,Sakamoto A,Saito S,Nishijima N,Nasu A,Arimoto A,Kita R,Kimura T

    更新日期:2015-03-01 00:00:00

  • Chemotherapy-induced modification of microRNA expression in esophageal cancer.

    abstract::Neoadjuvant chemotherapy is often used in the treatment of advanced esophageal cancer. In this study, we determined the impact of chemotherapy on microRNA (miRNA) expression in esophageal cancer cells, and whether identified changes might have biological relevance. Two esophageal carcinoma cell lines (one adenocarcino...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1381

    authors: Hummel R,Wang T,Watson DI,Michael MZ,Van der Hoek M,Haier J,Hussey DJ

    更新日期:2011-10-01 00:00:00

  • Vasohibin-1 inhibits angiogenesis and suppresses tumor growth in renal cell carcinoma.

    abstract::Vasohibin-1 (VASH1) has recently been isolated as a novel inhibitor of angiogenesis. Several studies have demonstrated that VASH1 plays important roles in tumor angiogenesis but the role of this angiogenic inhibitor in renal cell carcinoma (RCC) has not been elucidated. We previously reported that VASH1 expression is ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5746

    authors: Zhao G,Na R,Li L,Xiao H,Ding N,Sun Y,Han R

    更新日期:2017-08-01 00:00:00

  • A targeting peptide improves adenovirus-mediated transduction of a glioblastoma cell line.

    abstract::The progress of the application of adenovirus in cancer gene therapy is hindered by the lack of expression of native adenovirus receptor on a variety of cancer types. Hence, strategies are needed to retarget the adenoviral vector to non-native cellular surface receptors. In the present study, a new peptide SWDIAWPPLKV...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3065

    authors: Wang D,Li W,Zhang H,Mao Q,Xia H

    更新日期:2014-05-01 00:00:00

  • Expression spectra of matrix metalloproteinases in metastatic non-small cell lung cancer.

    abstract::By combining suppression subtractive hybridization and microarray to examine gene expressions between metastatic and non-metastatic non-small cell lung cancer (NSCLC), we have identified differential expression spectra of matrix metalloproteinases (MMP). Among MMPs, expressions of MMP-13, -14, -15 and -24 decreased, t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Lin TS,Chiou SH,Wang LS,Huang HH,Chiang SF,Shih AY,Chen YL,Chen CY,Hsu CP,Hsu NY,Chou MC,Kuo SJ,Chow KC

    更新日期:2004-10-01 00:00:00

  • Thioridazine, an antipsychotic drug, elicits potent antitumor effects in gastric cancer.

    abstract::Thioridazine, an antipsychotic drug, has been reported to induce apoptosis in various types of cancer cells, with specificity on targeting cancer stem cells (CSCs). However, whether it elicits anticancer effects in gastric cancer has never been reported. In the present study, we examined the ability of thioridazine to...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3068

    authors: Mu J,Xu H,Yang Y,Huang W,Xiao J,Li M,Tan Z,Ding Q,Zhang L,Lu J,Wu X,Liu Y

    更新日期:2014-05-01 00:00:00

  • Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease.

    abstract::Mast cell-derived chymase promotes inflammatory responses and tissue fibrosis. Although previous studies have reported changes in the number of mucosal mast cells in inflammatory bowel disease (IBD), the behaviour of chymase immunopositive mast cells has not been studied. In this study, we immunohistochemically invest...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Andoh A,Deguchi Y,Inatomi O,Yagi Y,Bamba S,Tsujikawa T,Fujiyama Y

    更新日期:2006-07-01 00:00:00

  • Increased expression of telomere-related proteins correlates with resistance to radiation in human laryngeal cancer cell lines.

    abstract::Telomere-associated proteins function as survival factors in telomere maintenance, which are major contributors to radiosensitivity in human cancers. The aim of this study was to investigate the association of telomere-associated gene expression and radiation resistance in human larynx squamous carcinoma. The changes ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000381

    authors: Tang T,Zhou FX,Lei H,Yu HJ,Xie CH,Zhou YF,Liu SQ

    更新日期:2009-06-01 00:00:00

  • miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma.

    abstract::Expression of miR-365 has been reported to be downregulated in hepatocellular carcinoma (HCC). However, the biological function and underlying mechanism of miR-365 in HCC growth and metastasis remain unclear. The aim of the present study was to explore the role of miR-365 in HCC progression. We found that miR-365 expr...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5423

    authors: Liu Y,Zhang W,Liu S,Liu K,Ji B,Wang Y

    更新日期:2017-03-01 00:00:00

  • Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer.

    abstract::Cisplatin (CDDP)‑based combination chemotherapy is the standard for muscle‑invasive bladder cancer (MIBC). However, nearly all patients undergoing CDDP chemotherapy become refractory due to the development of CDDP resistance. Therefore, clarification of the mechanisms of CDDP resistance is urgently needed. The transcr...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7039

    authors: Sekino Y,Sakamoto N,Ishikawa A,Honma R,Shigematsu Y,Hayashi T,Sentani K,Oue N,Teishima J,Matsubara A,Yasui W

    更新日期:2019-05-01 00:00:00

  • IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance.

    abstract::Inflammation is regarded as one of the major hallmarks of tumors, and has a very close relationship with gastric cancer. Interleukin-33 (IL-33), a new member of the IL-1 family, plays an important role in both inflammatory disease and tumors. The present study was designed to explore the effects of IL-33 on the prolif...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3898

    authors: Ye XL,Zhao YR,Weng GB,Chen YC,Wei XN,Shao JP,Ji H

    更新日期:2015-06-01 00:00:00

  • MicroRNA‑192 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting caveolin 1.

    abstract::It has been demonstrated that microRNA‑192 (miR‑192) serves important roles in different cancer types, including breast cancer, prostate cancer and colorectal cancer. However, its biological role and function in breast cancer remains largely unknown. The present study aimed to determine the role of miR‑192 in breast c...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7298

    authors: Chen P,Feng Y,Zhang H,Shi X,Li B,Ju W,Yu X,Zhang N,Luo X

    更新日期:2019-11-01 00:00:00